Repurposing immunosuppressants for antileukemia therapy is a research paper published in EMBO Molecular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: CA248019
National Institutes of Health
Grant: CA266256
National Institutes of Health
Grant: DK130478
National Institutes of Health
Grant: 5R01CA248019-02
The Role of HIF1A-DNMT3A axis in AML1/ETO-Driven Acute Myelogenous Leukemia
National Institutes of Health
Grant: 5R01DK130478-02
Mechanism of the short- and long-term effects of COVID-19-induced Alarmins on hematopoietic stem and progenitor cells.
National Institutes of Health
Grant: 5R01CA266256-02
Role of an Aberrant N6-Methyladenosine-LncRNA Axis in the Development and Maintenance of Drug Resistance through Regulating the Leukemia Stem Cell
Edward P. Evans Foundation
FWCI
0.30
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals